Literature DB >> 29967975

Antimicrobial susceptibilities of Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis strains from periodontitis patients in Morocco.

M Mínguez1, O K Ennibi2, P Perdiguero3, L Lakhdar2, L Abdellaoui2, M C Sánchez3, M Sanz1,4, David Herrera5,6.   

Abstract

BACKGROUND AND
OBJECTIVE: Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis have been frequently isolated in periodontitis patients in Morocco. Its persistence after the subgingival debridement of the biofilm has been correlated with worse clinical outcomes. The aim of this study was to evaluate the antimicrobial susceptibilities of A. actinomycetemcomitans and P. gingivalis, to amoxicillin, amoxicillin plus clavulanate, metronidazole, and azithromycin. In addition, microbiological profiles of patients harbouring A. actinomycetemcomitans, P. gingivalis, or both were compared.
MATERIAL AND METHODS: In 45 consecutive periodontitis Moroccan patients, subgingival samples were taken and processed by culture. Twenty-four A. actinomycetemcomitans and 30 P. gingivalis colonies were isolated (54 strains) and susceptibility tests, using the epsilometric method, were run for amoxicillin, amoxicillin plus clavulanate, metronidazole, and azithromycin. Minimum inhibitory concentrations for 50 (MIC50) and 90% (MIC90) of the organisms were calculated.
RESULTS: The prevalence of A. actinomycetemcomitans and P. gingivalis was 79.5 and 84.4%, respectively. A. actinomycetemcomitans showed susceptibility to amoxicillin, amoxicillin plus clavulanate, while 28% of the isolated strains were resistant to azithromycin and 61.7% towards metronidazole. No P. gingivalis resistance towards amoxicillin, amoxicillin plus clavulanate, metronidazole, and azithromycin was found.
CONCLUSION: A. actinomycetemcomitans and P. gingivalis were frequently detected in Moroccan patients with periodontitis, while antimicrobial resistance was only detected for A. actinomycetemcomitans to metronidazole and azithromycin. CLINICAL RELEVANCE: A. actinomycetemcomitans resistance against some antimicrobials in periodontitis patients in Morocco can influence the selection of the therapeutic approaches.

Entities:  

Keywords:  Aggregatibacter actinomycetemcomitans; Antimicrobial susceptibilities; Morocco; Periodontitis; Porphyromonas gingivalis

Mesh:

Substances:

Year:  2018        PMID: 29967975     DOI: 10.1007/s00784-018-2539-2

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  5 in total

Review 1.  Clinical and Microbiological Efficacy of Adjunctive Systemic Quinolones to Mechanical Therapy in Periodontitis: A Systematic Review of the Literature.

Authors:  Carlos-M Ardila; Jader-Alexander Bedoya-García
Journal:  Int J Dent       Date:  2022-05-21

2.  Antimicrobial resistance of microorganisms present in periodontal diseases: A systematic review and meta-analysis.

Authors:  Flávia Casale Abe; Katia Kodaira; Cristiane de Cássia Bergamaschi Motta; Silvio Barberato-Filho; Marcus Tolentino Silva; Caio Chaves Guimarães; Carolina Castro Martins; Luciane Cruz Lopes
Journal:  Front Microbiol       Date:  2022-10-03       Impact factor: 6.064

3.  Association among serum and salivary A. actinomycetemcomitans specific immunoglobulin antibodies and periodontitis.

Authors:  Gaetano Isola; Alessandro Polizzi; Romeo Patini; Sebastiano Ferlito; Angela Alibrandi; Giuseppe Palazzo
Journal:  BMC Oral Health       Date:  2020-10-15       Impact factor: 2.757

4.  The Antimicrobial Susceptibility of Porphyromonas gingivalis: Genetic Repertoire, Global Phenotype, and Review of the Literature.

Authors:  Georg Conrads; Tim Klomp; Dongmei Deng; Johannes-Simon Wenzler; Andreas Braun; Mohamed M H Abdelbary
Journal:  Antibiotics (Basel)       Date:  2021-11-24

5.  Discrepancies in Antimicrobial Susceptibility between the JP2 and the Non-JP2 Genotype of Aggregatibacter actinomycetemcomitans.

Authors:  Margareta Granlund; Carola Höglund Åberg; Anders Johansson; Rolf Claesson
Journal:  Antibiotics (Basel)       Date:  2022-02-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.